Maedica · 2026
Mycoplasma pneumoniae Infection in Children: Clinical Features and Outcomes.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taras Roxana, Nicolae Keon Theodore, Cinteza Eliza Elena, Ionescu Marcela Daniela
Аннотация
INTRODUCTION: Mycoplasma pneumoniae (MP) is a major cause of community-acquired respiratory infections, especially in school-aged children and young adults, with cyclical outbreaks occurring every few years.
MATERIAL AND METHODS: This study analyzed a cohort of pediatric patients treated in a tertiary hospital in Bucharest and compared the findings with data reported in the literature.
RESULTS: Elevated anti-MP antibody titers (IgG, IgA and IgM) were associated with increased leukocytosis, neutrophilia, complications and longer hospitalization. Fever, lobar involvement and complications were also linked to prolonged hospital stay.
CONCLUSIONS: Our findings are consistent with international data and reflect the typical epidemiological profile of MP infection in children. These results contribute to the characterization of MP infection in the post-COVID era and support the need for prospective studies to validate the identified prognostic markers.
MATERIAL AND METHODS: This study analyzed a cohort of pediatric patients treated in a tertiary hospital in Bucharest and compared the findings with data reported in the literature.
RESULTS: Elevated anti-MP antibody titers (IgG, IgA and IgM) were associated with increased leukocytosis, neutrophilia, complications and longer hospitalization. Fever, lobar involvement and complications were also linked to prolonged hospital stay.
CONCLUSIONS: Our findings are consistent with international data and reflect the typical epidemiological profile of MP infection in children. These results contribute to the characterization of MP infection in the post-COVID era and support the need for prospective studies to validate the identified prognostic markers.